Vaccination for COVID-19 using the AstraZeneca vaccine in North Sulawesi Province was temporarily suspended after residents who were vaccinated felt the effects such as fever, chills, headaches, body aches and weakness. Berita Terkini
“It has been temporarily stopped while waiting for an explanation and official statement from the Ministry of Health and WHO Indonesian Representatives regarding the official letter we sent March 26, 2021,” said the Head of the North Sulawesi Provincial Health Office, dr Debie KR Kalalo MScPH in Manado, quoted by Antara, Saturday (27/3) ).
The spokesman for the North Sulawesi COVID-19 Handling Acceleration Task Force, Dr. Steven Dandel MPH then clarified a number of points related to temporarily halting vaccinations using AstraZeneca.
He said that this was done as a precautionary measure considering that there was an incidence of Post-Immunization Associations (AEFI) of five to 10 percent of the total AstraZeneca vaccines. Berita Hari ini
AEFIs present in the form of symptoms of fever, chills, body aches, bone pain, nausea and vomiting. Doctor Steaven explained in the ‘Emergency Use Authorization’ (EUA) of the AstraZeneca vaccine, it has actually been stated that AEFI is an adverse effect, which is very frequent, meaning one in 10 injections) and often occurs (common -1 in 10). 1 in 100 injections).
“We need to prepare risk communication to the public to accept this fact. So that there is no panic in the community,” he said.
The risk communication taken, the first step, he said, was preceded by an investigation by the KIPI Komda together with the Health Office, Ministry of Health and WHO, before a media release was carried out. Berita Politik
“This step also needs to be taken to adjust the pattern and approach of vaccination, especially those that target business units or institutions. So that it is not done at the same time for employees. But gradually, so that the business unit does not need to be closed if there are many employees affected by AEFI,” he said. Finance Solutions